Načítá se...
CB2 receptor‐selective agonists as candidates for targeting infection, inflammation, and immunity in SARS‐CoV‐2 infections
The COVID‐19 pandemic caused by SARS‐CoV‐2 is a deadly disease afflicting millions. The pandemic continues affecting population due to nonavailability of drugs and vaccines. The pathogenesis and complications of infection mainly involve hyperimmune‐inflammatory responses. Thus, therapeutic strategie...
Uloženo v:
| Vydáno v: | Drug Dev Res |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley & Sons, Inc.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7753678/ https://ncbi.nlm.nih.gov/pubmed/33190277 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ddr.21752 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|